-transparent.png){kind=logo}
The preparation and biological activities of a series of pyrido[3,4-e]-1,2,4-triazines, 1,2,4-triazino[5,6-c]quinolines, and related fused triazines are described. Methyl, amino, and acylamino substituents were placed in the pyridyl ring of the former system. Other structural modifications included various alkyl, cycloalkyl, substituted phenyl, and heterocyclic groups in the 3-position of these ring systems. In agar dilution assays, actives in this series inhibited strains of Candida, Aspergillus, Mucor, and Trychophyton species at MIC's of less than or equal to 16 micrograms/mL.
Related Publications
M F Reich, and
P F Fabio, and
V J Lee, and
N A Kuck, and
R T Testa
March 1998,
Bioorganic & medicinal chemistry,
M F Reich, and
P F Fabio, and
V J Lee, and
N A Kuck, and
R T Testa
November 1985,
Journal of medicinal chemistry,
M F Reich, and
P F Fabio, and
V J Lee, and
N A Kuck, and
R T Testa
May 2017,
Archiv der Pharmazie,
M F Reich, and
P F Fabio, and
V J Lee, and
N A Kuck, and
R T Testa
May 2010,
Molecules (Basel, Switzerland),
M F Reich, and
P F Fabio, and
V J Lee, and
N A Kuck, and
R T Testa
November 2008,
Bioorganic & medicinal chemistry,
M F Reich, and
P F Fabio, and
V J Lee, and
N A Kuck, and
R T Testa
November 1990,
Journal of medicinal chemistry,
M F Reich, and
P F Fabio, and
V J Lee, and
N A Kuck, and
R T Testa
January 2010,
Bioorganic & medicinal chemistry letters,
M F Reich, and
P F Fabio, and
V J Lee, and
N A Kuck, and
R T Testa
November 1976,
The Journal of organic chemistry,
M F Reich, and
P F Fabio, and
V J Lee, and
N A Kuck, and
R T Testa
November 1986,
Die Pharmazie,
M F Reich, and
P F Fabio, and
V J Lee, and
N A Kuck, and
R T Testa
October 2012,
MedChemComm,
